BPC-157 is a synthetic peptide consisting of 15 amino acids, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is derived from a larger protective protein found in human gastric juice. The name stands for “Body Protection Compound,” reflecting its origin in early research into gastric mucosal protection.
Unlike many peptides, which are broken down quickly in biological systems, BPC-157 has shown notable stability, including resistance to degradation in an acidic environment. It does not appear to act through a single known receptor — instead, its observed effects in research models seem to result from a cascade of downstream influences on growth factor signalling, nitric oxide pathways, and angiogenesis.
Documented Research Areas
Angiogenesis and Vascular Signalling
A substantial body of preclinical research has focused on BPC-157’s relationship to angiogenesis — the formation of new blood vessels. Several studies have reported increased expression of VEGFR2 (vascular endothelial growth factor receptor 2) in tissue exposed to the peptide, a finding that recurs consistently across the published literature on this compound.
Gastrointestinal Models
Much of the foundational research literature on BPC-157 involves the gastrointestinal tract, given its discovery context. In models of NSAID-induced gastric injury, ethanol-induced mucosal damage, and stress-induced lesions, BPC-157 administration has been associated with reduced lesion area and lower histological damage scores relative to control groups.
Research has also examined the peptide’s interaction with nitric oxide signalling pathways, particularly the balance between constitutive and inducible nitric oxide synthase activity in inflamed gastrointestinal tissue.
Chronic Lesion and Tissue Repair Models
In chronic ulcer models — induced through methods such as cysteamine or acetic acid application — research groups have reported faster re-epithelialization, increased granulation tissue formation, and improved angiogenesis within the affected area.
Musculoskeletal Research
A smaller body of preliminary research has explored BPC-157 in models of bone repair, including segmental bone defects and fracture healing, with some studies reporting enhanced osteoblast activity.
What the Research Does Not Establish
A 2025 systematic review covering studies published between 1993 and 2025 noted that despite this body of preclinical literature, BPC-157 lacks regulatory approval, and the review’s authors specifically set out to synthesise the mechanism of action and safety profile rather than confirm any therapeutic application.
Human-trial data remains limited. Researchers working with this compound should treat it as a tool for investigating the underlying angiogenic and tissue-repair pathways it appears to influence — not as a substance with established outcomes in humans.
Considerations for Research Use
BPC-157 appears on the WADA Prohibited List under category S0 (Unapproved Substances), prohibited at all times, both in and out of competition.
There is no human evidence linking the compound to cancer. The theoretical concern raised in the literature relates to its angiogenic activity, since tumour growth also depends on the establishment of a blood supply. Animal carcinogenicity studies to date have not observed a tumour-promoting effect at research doses.
Sourcing Research-Grade BPC-157
Any BPC-157 used in a laboratory setting should be accompanied by a batch-specific Certificate of Analysis confirming identity via mass spectrometry, purity via HPLC analysis, and screening for heavy metals and endotoxins. At Claripep, every batch is independently tested by a third-party laboratory before listing. For researchers also working with TB-500, see our comparison of the two compounds’ distinct mechanisms.
This article is provided for research and educational purposes only. It does not constitute medical advice and should not be interpreted as promoting human or veterinary use of this compound. All products supplied by Claripep Ltd are intended strictly for laboratory research applications.